Center Scientists
To read brainSTIM's 'Center Highlight' featuring Center Scientist Nicholas Balderston PhD, click here.
- Brian Erickson, PhD
- Denise Harvey, PhD
- Golkoo Hosseini, MD, MSEd
- Robert L. Seilheimer, MD, PhD
- Kelly Sloane, MD
Brian Erickson, PhD
Brian Erickson, PhD, is a Research Assistant Professor at Drexel University's Cognitive Neuroengineering and Wellbeing Research Lab (CogNeW). Dr. Erickson's main interest is in connecting technology to neurology to improve health outcomes, develop of cognitive enhancements for healthy people, and discover principles of communication between the brain and machines, and utilizes his background in engineering frequently when approaching his work in cognitive neuroscience. His primary projects involve brain stimulation (TMS), non-invasive recording (EEG and MRI), and network theory.
Denise Harvey, PhD
Research Assistant Professor of Neurology, University of Pennsylvania
Adjunct Professor of Cognitive Psychology, Drexel University
Research Associate, Laboratory for Cognition and Neural Stimulation (LCNS), University of Pennsylvania
Golkoo Hosseini, MD, MSEd
Golkoo Hosseini, MD, MSED, is a board-certified psychiatrist and practicing clinician at the Penn Psychiatry Clinic and Penn Intervention Psychiatry Program. Dr. Hosseini is an Assistant Professor of Clinical Psychiatry, as well as the Associate Program Director for the Psychiatry Residency Training at the University of Pennsylvania School of Medicine. Dr. Hosseini collaborates with the Mood and Anxiety Disorders Treatment and Research Program, the Center for Neuromodulation of Depression and Stress, and the Neurosurgery Clinical Research Division at the University of Pennsylvania.
Robert L. Seilheimer, MD, PhD
Robert Seilheimer, MD, PhD, is a T32 Research Fellow and Interventional Psychiatrist whose clinical practice and research is focused on neuromodulation. He works with Dr. Casey Halpern and Dr. Katherine Scangos on studies of circuit-based and electrophysiology-informed deep brain stimulation for the treatment of severe, refractory psychiatric disorders, including obsessive-compulsive disorder, major depressive disorder, and substance use disorders. Clinically, he sees patients with treatment-refractory psychiatric conditions for neuromodulation, including TMS, ECT, and DBS.
Kelly Sloane, MD
Kelly Sloane, MD, received her B.A. in Classics at University of Pennsylvania. She received her M.D. from Johns Hopkins School of Medicine and went on to complete her residency in Neurology at Johns Hopkins Hospital. After residency, she earned fellowships in Vascular Neurology at Massachusetts General Hospital/Brigham and Women’s Hospital as well as Neurorecovery at Mass General/Spaulding Rehabilitation Hospital.
Dr. Sloane’s clinical and research interests focus on recovery of cognitive function after stroke as well as healthcare technology. She has led studies on motor-cognitive recovery after stroke and technology-based cognitive assessment tools, and she is the author of numerous peer-reviewed publications of her research. In addition to her clinical work, Dr. Sloane is also a Co-Primary Investigator at the University of Pennsylvania's Laboratory for Cognition and Neural Stimulation (LCNS).